Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOUND FOR INHIBITING IRAK4 ACTIVITY AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/017381
Kind Code:
A1
Abstract:
The present application relates to a compound for inhibiting IRAK4 activity and a use thereof, and specifically provides a compound as represented by formula A, or an enantiomer, a diastereoisomer, a racemate, a tautomer, a stereoisomer, a geometric isomer, a nitrogen oxide, a metabolite or a pharmaceutically acceptable salt, an ester, a solvate, a hydrate, an isotope-labeled compound (preferably a deuterated substance), or a prodrug thereof.

Inventors:
DU XINMING (CN)
XU HE (CN)
DU LIFEI (CN)
CHEN ZHAOQIANG (CN)
LI YUANPENG (CN)
MI YUTAO (CN)
QU MENGYANG (CN)
JIA JILONG (CN)
MA JUNJUN (CN)
ZOU JUNJIE (CN)
ZOU RONGFENG (CN)
WEN XIAOMING (CN)
WANG SHAOHUI (CN)
CHEN BIN (CN)
ZHANG PEIYU (CN)
Application Number:
PCT/CN2023/108727
Publication Date:
January 25, 2024
Filing Date:
July 21, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHENZHEN ZHONGGE BIOLOGICAL TECH CO LTD (CN)
International Classes:
C07D403/14; A61K31/4162; A61K31/4192; A61P35/00; A61P37/00; C07D405/14; C07D519/00
Foreign References:
CN112480101A2021-03-12
CN106749268A2017-05-31
CN111560012A2020-08-21
US20160152608A12016-06-02
Attorney, Agent or Firm:
IPSUNNY (CN)
Download PDF: